Organon & Co.
OGN
$7.18
$0.010.14%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.50% | 5.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.50% | 5.35% | |||
| Cost of Revenue | 3.24% | 7.09% | |||
| Gross Profit | -1.70% | 4.00% | |||
| SG&A Expenses | -8.39% | 7.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.07% | 6.70% | |||
| Operating Income | 10.12% | 0.60% | |||
| Income Before Tax | 6.11% | 126.73% | |||
| Income Tax Expenses | -1.19% | 500.00% | |||
| Earnings from Continuing Operations | 10.34% | 66.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.34% | 66.67% | |||
| EBIT | 10.12% | 0.60% | |||
| EBITDA | 8.71% | 1.67% | |||
| EPS Basic | 10.33% | 65.32% | |||
| Normalized Basic EPS | 30.73% | -9.18% | |||
| EPS Diluted | 9.36% | 69.03% | |||
| Normalized Diluted EPS | 30.50% | -8.16% | |||
| Average Basic Shares Outstanding | 0.01% | 0.81% | |||
| Average Diluted Shares Outstanding | 0.19% | -0.32% | |||
| Dividend Per Share | 0.00% | -92.86% | |||
| Payout Ratio | -0.73% | -0.92% | |||